DE60210976D1 - Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung - Google Patents

Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Info

Publication number
DE60210976D1
DE60210976D1 DE60210976T DE60210976T DE60210976D1 DE 60210976 D1 DE60210976 D1 DE 60210976D1 DE 60210976 T DE60210976 T DE 60210976T DE 60210976 T DE60210976 T DE 60210976T DE 60210976 D1 DE60210976 D1 DE 60210976D1
Authority
DE
Germany
Prior art keywords
prevention
treatment
phenyl
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60210976T
Other languages
English (en)
Other versions
DE60210976T2 (de
Inventor
Carlos Plata-Salaman
Boyu Zhao
Roy Twyman
Moon Choi
Robert Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60210976D1 publication Critical patent/DE60210976D1/de
Publication of DE60210976T2 publication Critical patent/DE60210976T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE60210976T 2001-02-27 2002-02-21 Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung Expired - Lifetime DE60210976T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US271681P 2001-02-27
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
DE60210976D1 true DE60210976D1 (de) 2006-06-01
DE60210976T2 DE60210976T2 (de) 2007-05-24

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210976T Expired - Lifetime DE60210976T2 (de) 2001-02-27 2002-02-21 Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Country Status (27)

Country Link
US (1) US6562867B2 (de)
EP (1) EP1408953B1 (de)
JP (1) JP4276837B2 (de)
KR (1) KR100946944B1 (de)
CN (1) CN1250215C (de)
AT (1) ATE324108T1 (de)
BR (1) BR0207644A (de)
CA (1) CA2439475C (de)
CY (1) CY1105330T1 (de)
CZ (1) CZ20032300A3 (de)
DE (1) DE60210976T2 (de)
DK (1) DK1408953T3 (de)
ES (1) ES2262801T3 (de)
HK (1) HK1063436A1 (de)
HU (1) HUP0303243A3 (de)
IL (1) IL157590A0 (de)
MX (1) MXPA03007717A (de)
MY (1) MY129304A (de)
NO (1) NO20033802L (de)
NZ (1) NZ527988A (de)
PL (1) PL364638A1 (de)
PT (1) PT1408953E (de)
RS (1) RS50677B (de)
RU (1) RU2300372C2 (de)
TW (1) TWI250872B (de)
WO (1) WO2002067921A1 (de)
ZA (1) ZA200307465B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112713A (pt) * 2000-07-21 2003-07-22 Ortho Mcneil Pharm Inc "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia
CN1235579C (zh) * 2001-02-27 2006-01-11 奥索-麦克尼尔药品公司 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
RS50505B (sr) * 2001-02-27 2010-03-02 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja
PT1408954E (pt) 2001-07-16 2009-07-28 Ortho Mcneil Janssen Pharm Compostos carbamatos para utilização na prevenção ou tratamento da dor neuropática
US20060194873A1 (en) * 2004-09-16 2006-08-31 Choi Yong M Methods of treating epileptogenesis and epilepsy
WO2006133393A1 (en) 2005-06-08 2006-12-14 Sk Holdings Co., Ltd. Treatment of sleep-wake disorders
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
MX2009004770A (es) * 2006-10-30 2009-08-17 Janssen Pharmaceutica Nv Compuestos de carbamato para usarse en el tratamiento de la depresion.
MX2009004798A (es) * 2006-10-31 2009-08-12 Janssen Pharmaceutica Nv Tratamiento de los trastornos generalizados del desarrollo.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR101758543B1 (ko) * 2013-03-12 2017-07-14 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경가스에 의한 질환의 예방 또는 치료용 조성물
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
BR112019011930A2 (pt) * 2016-12-14 2019-10-29 Sk Biopharmaceuticals Co Ltd medicamento, composição farmacêutica, método para prevenir, aliviar ou tratar transtorno bipolar em um indivíduo, e, uso de um composto de carbamato.
KR20200016889A (ko) 2017-06-02 2020-02-17 재즈 파마슈티칼즈 아일랜드 리미티드 과다 졸림증을 치료하기 위한 방법 및 조성물
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
KR20030087010A (ko) 2003-11-12
PL364638A1 (en) 2004-12-13
DK1408953T3 (da) 2006-08-21
CA2439475A1 (en) 2002-09-06
RU2300372C2 (ru) 2007-06-10
JP4276837B2 (ja) 2009-06-10
IL157590A0 (en) 2004-03-28
CY1105330T1 (el) 2010-03-03
DE60210976T2 (de) 2007-05-24
EP1408953B1 (de) 2006-04-26
JP2004533415A (ja) 2004-11-04
HK1063436A1 (en) 2004-12-31
CN1250215C (zh) 2006-04-12
WO2002067921A1 (en) 2002-09-06
MY129304A (en) 2007-03-30
HUP0303243A2 (hu) 2004-01-28
ZA200307465B (en) 2005-03-17
EP1408953A1 (de) 2004-04-21
US6562867B2 (en) 2003-05-13
ES2262801T3 (es) 2006-12-01
RS50677B (sr) 2010-06-30
YU67803A (sh) 2006-08-17
KR100946944B1 (ko) 2010-03-15
BR0207644A (pt) 2004-03-09
CZ20032300A3 (cs) 2005-01-12
CN1505506A (zh) 2004-06-16
RU2003128997A (ru) 2005-03-20
PT1408953E (pt) 2006-07-31
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
HUP0303243A3 (en) 2012-07-30
NO20033802L (no) 2003-10-22
TWI250872B (en) 2006-03-11
NO20033802D0 (no) 2003-08-26
US20020198257A1 (en) 2002-12-26
CA2439475C (en) 2010-05-18
ATE324108T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
DE602005020667D1 (de) Verwendung von 2-phenyl-1,2-ethanediol-(di)carbamaten zur behandlung von epileptogenese
ATE538784T1 (de) Verfahren zur behandlung von substanzbedingten erkrankungen
DE60210976D1 (de) Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
ATE378046T1 (de) Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
RS67603A (en) Carbamate compounds for use in the treatment of pain
DE60210960D1 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
PT1305082E (pt) Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
DE60232796D1 (de) Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders

Legal Events

Date Code Title Description
8364 No opposition during term of opposition